Effects of combination estrogen plus progestin hormone treatment on cognition and affect

The Journal of Clinical Endocrinology and Metabolism
S M ResnickWomen's Health Initiative Study of Cognitive Aging Investigators

Abstract

Some studies of hormone treatment in postmenopausal women suggest benefits on specific cognitive functions, particularly memory. The objective of this study was to determine whether hormone therapy influences changes in specific cognitive functions and affect in older women. This study was a randomized, double-blind, placebo-controlled clinical trial. Participants were women from 14 of 40 clinical centers of the Women's Health Initiative (WHI). Postmenopausal women (1416) aged 65 yr and older, free of probable dementia, and enrolled in WHI and the WHI Memory Study (WHIMS) trial of combination estrogen and progestin for a mean of 3 yr and followed for a mean of 1.35 yr, were studied. Intervention was conjugated equine estrogen (CEE; 0.625 mg) with 2.5 mg medroxyprogesterone acetate (MPA) in one daily tablet (CEE + MPA) or placebo. Annual rates of change in specific cognitive functions and affect, adjusted for time since randomization, were measured. CEE + MPA had a negative impact on verbal memory (P <or= 0.01) and a trend to a positive impact on figural memory (P = 0.012) over time compared with placebo, but other cognitive domains were not affected. Both effects on memory were evident only after long-term therapy. CEE + MPA di...Continue Reading

Associated Clinical Trials

Citations

Mar 23, 2010·Breast Cancer Research and Treatment·Jeanne DebessMarianne Ewertz
Mar 12, 2009·Age·Sanjay AsthanaUNKNOWN Cognitive Aging Work Group
Jun 11, 2010·Current Neurology and Neuroscience Reports·Sarah C Janicki, Nicole Schupf
Dec 13, 2007·International Psychogeriatrics·Joanne RyanMarie-Laure Ancelin
Jul 24, 2008·Nature Clinical Practice. Endocrinology & Metabolism·Pauline M Maki
Oct 22, 2009·Nature Reviews. Endocrinology·Barbara B Sherwin
Aug 19, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Paul A NewhouseSimon N Young
Apr 30, 2009·Seminars in Reproductive Medicine·Victor W Henderson
Sep 10, 2008·Epidemiologic Reviews·Nicola ColeyAlain Grand
May 27, 2009·Human Reproduction Update·Pauline M Maki, Erin Sundermann
Dec 30, 2006·Menopause : the Journal of the North American Menopause Society·Erin S LeBlancJeri S Janowsky
May 4, 2007·Menopause : the Journal of the North American Menopause Society·Victor W Henderson, Barbara B Sherwin
Apr 23, 2008·Menopause : the Journal of the North American Menopause Society·Charles L LoprinziBrad Christensen
Jun 20, 2008·Menopause : the Journal of the North American Menopause Society·Pauline M MakiStacie E Geller
Jun 27, 2008·Menopause : the Journal of the North American Menopause Society·Wulf H UtianUNKNOWN North American Menopause Society
Jul 11, 2009·Menopause : the Journal of the North American Menopause Society·Pauline M MakiStacie E Geller
Mar 20, 2010·Menopause : the Journal of the North American Menopause Society·Alison Berent-SpillsonYolanda R Smith
Jul 10, 2010·Menopause : the Journal of the North American Menopause Society·Claudio N Soares, Pauline M Maki
Jul 10, 2010·Menopause : the Journal of the North American Menopause Society·Paul A NewhouseSimon N Young
Sep 20, 2011·Menopause : the Journal of the North American Menopause Society·Zahiruddin OthmanWan Mohd Zahiruddin Wan Mohammad
Dec 31, 2011·Menopause : the Journal of the North American Menopause Society·Carey E GleasonSanjay Asthana
Dec 30, 2011·Menopause : the Journal of the North American Menopause Society·Vinod Yalamanchili, J Christopher Gallagher
Mar 1, 2012·Menopause : the Journal of the North American Menopause Society·Milena M Weinstein
Aug 5, 2008·Clinical Obstetrics and Gynecology·Victor W Henderson
Dec 10, 2009·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·Victor W Henderson
Apr 4, 2009·Genome Medicine·Dimitrios Avramopoulos
Sep 6, 2008·Endocrinology·Angela M WongCaleb E Finch
Oct 24, 2009·The Journal of Clinical Endocrinology and Metabolism·Susan M ResnickUNKNOWN Women's Health Initiative Study of Cognitive Aging Investigators
Aug 26, 2011·The Journal of Clinical Endocrinology and Metabolism·Yolanda R SmithJon-Kar Zubieta
Sep 30, 2010·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Heather A Bimonte-NelsonJoshua S Talboom
Oct 1, 2009·Future Medicinal Chemistry·Cheryl A Frye
Jan 24, 2014·Current Gerontology and Geriatrics Research·Leslie VaughanMark A Espeland
Jan 22, 2010·Women's Health·Jennifer G RobinsonWilliam Harris
Dec 24, 2010·Women's Health·Victor W Henderson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.